论文部分内容阅读
许多化疗药物的血液学毒性,特别是化疗相关性白细胞减少CIL,严重影响患者的治疗和生活质量。我们收集了50例肺癌患者临床资料,通过患者应用化疗药物和重组粒细胞集落刺激因子G-CSF之后,白细胞的变化情况,探讨化疗药物和生白药物影响白细胞的变化规律,为临床治疗CIL提供参考。1资料与方法1.1临床资料收集2003年7月至2008年7月在我院住院治疗的肺癌50例,年龄41~76岁,男性36例,女性14例,经
The hematologic toxicity of many chemotherapeutic agents, particularly chemotherapy-associated leukopenia, significantly affects the patient’s treatment and quality of life. We collected 50 cases of lung cancer clinical data, through the application of chemotherapy drugs and recombinant human granulocyte colony stimulating factor G-CSF leukocyte changes in patients with chemotherapy drugs and white drug effects of leukocyte changes, for the clinical treatment of CIL reference. 1 Materials and Methods 1.1 Clinical data collected from July 2003 to July 2008 in our hospital for treatment of lung cancer in 50 cases, aged 41 to 76 years, 36 males and 14 females,